IRIS
ARBITRIO, Mariamena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 617
EU - Europa 488
AS - Asia 324
SA - Sud America 18
AF - Africa 17
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 5
Totale 1.475
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 592
IT - Italia 293
SG - Singapore 152
GB - Regno Unito 62
IN - India 40
DE - Germania 28
CN - Cina 25
JO - Giordania 21
SE - Svezia 18
HK - Hong Kong 17
PK - Pakistan 17
CA - Canada 16
NL - Olanda 15
ID - Indonesia 12
FI - Finlandia 11
BR - Brasile 9
ES - Italia 9
FR - Francia 9
RU - Federazione Russa 9
SA - Arabia Saudita 9
LT - Lituania 7
PT - Portogallo 7
AE - Emirati Arabi Uniti 6
AU - Australia 5
CZ - Repubblica Ceca 5
EG - Egitto 5
IE - Irlanda 5
IR - Iran 5
MX - Messico 5
CY - Cipro 4
EU - Europa 4
ZA - Sudafrica 4
BG - Bulgaria 3
ET - Etiopia 3
KR - Corea 3
LB - Libano 3
NG - Nigeria 3
PE - Perù 3
CO - Colombia 2
EC - Ecuador 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
LK - Sri Lanka 2
MA - Marocco 2
MY - Malesia 2
PH - Filippine 2
PS - Palestinian Territory 2
UA - Ucraina 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
CH - Svizzera 1
CL - Cile 1
IQ - Iraq 1
NZ - Nuova Zelanda 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
VN - Vietnam 1
Totale 1.475
Salva come PNG Salva come JPEG
Città #
Chandler 124
Singapore 93
Chicago 44
Santa Clara 40
London 37
Ashburn 33
Milan 25
Lawrence 24
Princeton 24
Catanzaro 22
Naples 15
Amman 13
Hong Kong 12
Helsinki 11
Boardman 10
Ottawa 10
Parma 10
San Nicola Manfredi 10
Spezzano della Sila 10
Wilmington 10
Rome 9
Delhi 8
Irbid 8
Kaunas 7
Madrid 7
Santo Stefano di Rogliano 7
Cosenza 6
Ercolano 6
Los Angeles 6
The Dalles 6
Cardiff 5
Des Moines 5
Frankfurt am Main 5
Lucknow 5
Munich 5
Redmond 5
Riyadh 5
Sacramento 5
Brescia 4
Jeddah 4
Lahore 4
New York 4
Nicosia 4
Pune 4
Redwood City 4
West Jordan 4
Acquaviva delle Fonti 3
Addis Ababa 3
Afragola 3
Ajman 3
Banyumas 3
Berlin 3
Bristol 3
Castrovillari 3
Catania 3
Dubai 3
Grottaglie 3
Hyderabad 3
Islamabad 3
Lima 3
Melito di Porto Salvo 3
Mileto 3
Nuremberg 3
Olomouc 3
Oxford 3
Palermo 3
Paola 3
Quţūr 3
Richmond 3
San Antonio 3
Santo Tirso 3
Seattle 3
Seoul 3
Shanghai 3
Sofia 3
Waterford 3
Agrigento 2
Assago 2
Asyut 2
Augusta 2
Bekasi 2
Bogotá 2
Bologna 2
Buffalo 2
Campobello di Licata 2
Cape Town 2
Chennai 2
Colombo 2
Dublin 2
Edmonton 2
Florianópolis 2
Gesuiti 2
Guatemala City 2
Hanover 2
Hradec Králové 2
Ibarra 2
Joinville 2
Kuala Lumpur 2
Las Vegas 2
Makassar 2
Totale 857
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 312
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 73
miR-22 suppresses DNA ligase III addiction in multiple myeloma 73
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 52
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 51
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 47
DMET-Analyzer: automatic analysis of Affymetrix DMET Data 46
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 45
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling 42
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 41
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 39
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 38
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 36
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 35
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 35
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 35
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 35
Mmrf-commpass data integration and analysis for identifying prognostic markers 34
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 33
Pharmacogenomic Profiling of ADME Gene Variants: Current Challenges and Validation Perspectives 32
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 32
null 31
From single level analysis to multi-omics integrative approaches: A powerful strategy towards the precision oncology 30
Mir-22 modulates lenalidomide activity by counteracting myc addiction in multiple myeloma 29
Integration of DNA Microarray with Clinical and Genomic Data 29
Genetic variants associated with gastrointestinal symptoms in Fabry disease. 26
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats 26
A Prognostic and Carboplatin Response Predictive Model in Ovarian Cancer: A Mono-Institutional Retrospective Study Based on Clinics and Pharmacogenomics 25
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes 24
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma 23
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma 22
Mirnas and lncrnas as novel therapeutic targets to improve cancer immunotherapy 22
Ethical Perspectives on Pharmacogenomic Profiling 17
Development and validation of bioanalytical methods for LNA-i-miR-221 quantification in human plasma and urine by LC-MS/MS 17
Genetic variants associated with Fabry disease progression despite enzyme replacement therapy 17
From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology 14
Pembrolizumab plus lenvatinib in advanced endometrial cancer: case report and systematic review of lung toxicity 12
Identification of ADME genes polymorphic variants linked to trastuzumab-induced cardiotoxicity in breast cancer patients: Case series of mono-institutional experience 10
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 9
Genetic Biomarkers of Sorafenib Response in Patients with Hepatocellular Carcinoma 9
Autophagy and neuroprotection in astrocytes exposed to 6-hydroxydopamine is negatively regulated by NQO2: relevance to Parkinson’s disease 7
Polymorphisms and Pharmacogenomics of NQO2: The Past and the Future 6
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity 4
The impact of PARP inhibitors in the whole scenario of ovarian cancer management: A systematic review and network meta-analysis 3
null 2
Totale 1.580
Salva come PNG Salva come JPEG
Categoria #
all - tutte 14.359
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.359
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0 0 0 0 0 0 0 0 0 0 10 11
2020/202163 6 1 4 7 6 6 6 7 8 11 1 0
2021/2022128 2 0 0 22 5 2 10 22 30 17 13 5
2022/2023376 54 28 29 10 42 30 5 28 40 42 47 21
2023/2024469 87 34 42 37 41 70 27 38 10 17 32 34
2024/2025512 74 20 28 42 51 109 51 53 51 22 11 0
Totale 1.580